Literature DB >> 238860

Attenuation of hydrochlorothiazide-induced hypokalemia in dogs by a beta-adrenergic blocking drug, timolol.

C S Sweet, S L Gaul.   

Abstract

Hydrochlorothiazide, administered at 1, 3 and 9 mg/kg/day p.o. for 4 days, produced a dose-dependent lowering of plasma potassium and an elevation in plasma renin activity in unanesthetized dogs. When plasma renin activity was suppressed in diuretic-treated dogs by the potent beta-adrenergic receptor-blocking drug, timolol (0.5, 2 mg/kg/day p.o. for 4 days), the hypokalemia and hyperreninemia were significantly less pronounced. The data suggest that beta-adrenergic blocking drugs can be used to antagonize these side effects of diuretics.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 238860     DOI: 10.1016/0014-2999(75)90307-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  Effect of diuretic, beta-adrenoceptor blocking agent and their combination on elevated blood pressure and serum potassium: a cross-over study.

Authors:  P J Neuvonen; P J Pentikäinen; A J Jounela
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

3.  Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men.

Authors:  K Laustiola; A Uusitalo; T Koivula; A Sovijärvi; E Seppälä; T Nikkari; H Vapaatalo
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Hypokalaemia induced by a combination of a beta-blocker and a thiazide.

Authors:  J D Skehan; J N Barnes; P J Drew; P Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

5.  Fixed combination of sotalol and hydrochlorothiazide in the treatment of uncomplicated hypertension.

Authors:  A Jäättelä
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Timolol and bendrofluazide in the management of hypertension in general practice.

Authors:  D Wheatley
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.